Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats

被引:45
作者
Briscoe, RJ
Cabrera, CL
Baird, TJ
Rice, KC
Woods, JH [1 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] NIDDK, NIH, Bethesda, MD 20892 USA
[3] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA
关键词
corticotropin releasing hormone; corticotropin releasing hormone antagonist; alpha-helical CRH9-41; antalarmin; blood pressure; rat;
D O I
10.1016/S0006-8993(00)02742-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Central administration of CRH results in endocrinological. cardiovascular, and behavioral effects that suggest stress or anxiety. Among these is a marked presser response. Parenteral administration of CRH, however, results in hypotension. We used parenteral administration of antalarmin, a novel, small molecule CRH1 receptor antagonist, and alpha -helical CRH9-41, a peptidic CRHR1/CRHR2 antagonist to attempt to determine the receptor mechanisms through which CRH is acting in both of these situations. Our results suggest that the hypertension produced by central CRH administration is mediated through central CRHR1 receptors, whereas the hypertension produced by parenteral CRH administration is mediated through peripheral CRHR2 receptors. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:204 / 207
页数:4
相关论文
共 14 条
  • [1] Corticotrophin-releasing factor receptors: From molecular biology to drug design
    Chalmers, DT
    Lovenberg, TW
    Grigoriadis, DE
    Behan, DP
    DeSouza, EB
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (04) : 166 - 172
  • [2] CHALMERS DT, 1995, J NEUROSCI, V15, P6340
  • [3] ATTENUATION OF CORTICOTROPIN RELEASING FACTOR-INDUCED HYPOTENSION IN ANESTHETIZED RATS WITH THE CRF ANTAGONIST, ALPHA-HELICAL CRF9-41 - COMPARISON WITH EFFECT ON ACTH RELEASE
    CORDER, R
    TURNILL, D
    LING, N
    GAILLARD, RC
    [J]. PEPTIDES, 1992, 13 (01) : 1 - 6
  • [4] Corticotropin-releasing factor receptors: An overview
    Dieterich, KD
    Lehnert, H
    DeSouza, EB
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (02) : 65 - 82
  • [5] Griebel G, 1998, PSYCHOPHARMACOLOGY, V138, P55
  • [6] Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
    Heinrichs, SC
    Lapsansky, J
    Lovenberg, TW
    DeSouza, EB
    Chalmers, DT
    [J]. REGULATORY PEPTIDES, 1997, 71 (01) : 15 - 21
  • [7] Long-term measurement of arterial blood pressure in conscious mice
    Mattson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1998, 274 (02) : R564 - R570
  • [8] McCarthy JR, 1999, CURR PHARM DESIGN, V5, P289
  • [9] THE CENTRAL ROLE OF CORTICOTROPIN-RELEASING FACTOR (CRF-41) IN PSYCHOLOGICAL STRESS IN RATS
    MORIMOTO, A
    NAKAMORI, T
    MORIMOTO, K
    TAN, N
    MURAKAMI, N
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1993, 460 : 221 - 229
  • [10] CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
    Schulz, DW
    Mansbach, RS
    Sprouse, J
    Braselton, JP
    Collins, J
    Corman, M
    Dunaiskis, A
    Faraci, S
    Schmidt, AW
    Seeger, T
    Seymour, P
    Tingley, FD
    Winston, EN
    Chen, YL
    Heym, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) : 10477 - 10482